Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-25 @ 5:05 AM
NCT ID:
NCT03143218
Eligibility Criteria:
Inclusion Criteria:
* The child is a permanent resident of the study area and likely to remain a resident for the duration of the trial
* The child is 5 - 17 months of age at the time of first vaccination
* A parent or legally recognised guardian provides informed consent for the child to join the trial
Exclusion Criteria:
* The child is a transient resident in the study area
* The child is in care
* The age of the child is outside the stipulated range
* The child has a history of an adverse reaction to SP or AQ
* The child has a serious underlying illness, including known HIV infection, unless this is well controlled by treatment, or severe malnutrition (weight for age or mid arm circumference Z scores \< 3 SD)
* The child is known to have an immune deficiency disease or is receiving an immunosuppressive drug
* The child has previously received a malaria vaccine.
* The child is enrolled in another malaria intervention trial
* The parents or guardians do not provide informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
5 Months
Maximum Age:
17 Months
Study:
NCT03143218
Study Brief:
Protocol Section:
NCT03143218